Clinical Trial

HPV Ends Here: Increasing Uptake of the HPV Vaccine

Study acronym: HPV
Recruiting
View on ClinicalTrials.gov →
Summary
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Protocol Amendment History 1 change
critical Enrollment reopened 2026-08-12
Trial Details
NCT Number NCT06831929
Lead Sponsor University of California, Davis
Collaborators: National Cancer Institute (NCI)
Conditions HPV Vaccine
Enrollment 2,232 participants
Start Date 2025-02-28
Primary Completion 2026-02-05 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-11